References
- Andersen, R. J. and D. E. Williams. 2000. Pharmaceuticals from the sea, pp. 55-79. In R. E. Hester and R. M. Harrison (eds.), Chemistry in the Marine Environment. The Royal Society of Chemistry, Cambridge
- Appell, M., J. L. Berfield, L. C. Wang, W. J. Dunn, N. Chen, and M. E. A. Reith. 2004. Structure-activity relationships for substrate recognition by the human dopamine transporter. Biochem. Pharmacol. 67: 293-302 https://doi.org/10.1016/j.bcp.2003.09.013
- Blunt, J. W., P. R. Copp, M. H. Munro, P. T. Northcote, and M. R. Prinsep. 2003. Marine natural products. Nat. Prod. Rep. 20: 1-48 https://doi.org/10.1039/b207130b
-
Hans, F. 1962. Oxydativer abbau
$\alpha$ -substituierter carbonsauren. Chem. Ber. 95: 2238-2242 https://doi.org/10.1002/cber.19620950922 - Li, X., M. K. Kim, U. Lee, S.-K. Kim, J. S. Kang, H. D. Choi, and B. W. Son. 2005. Myrothenones A and B, cyclopentenone derivatives with tyrosinase inhibitory activity from the marine-derived fungus Myrothecium sp. Chem. Pharm. Bull. 53: 453-455 https://doi.org/10.1248/cpb.53.453
- Li, X. F., Y. Li, K. W. Nam, D.-S. Kim, H. D. Choi, and B. W. Son. 2002. Screening of radical scavenging activity from the marine-derived fungus. Kor. J. Pharmacogn. 33: 219-223
-
Pouchert, C. J. and J. Behnke. 1993. The Aldrich Library of
$^{13}C$ and$^1H$ FT NMR Spectra, p.1037. 1st Ed. Vol. 2. Aldrich Chemical Company, Inc., U.S.A -
Pouchert, C. J. and J. Behnke. 1993. The Aldrich Library of
$^{13}C$ and$^1H$ FT NMR Spectra, p.1018. 1st Ed. Vol. 2. Aldrich Chemical Company, Inc., U.S.A - Umehara, K., K. Yoshida, M. Okamoto, M. Iwami, H. Tanaka, M. Kohsaka, and H. Imanaka. 1984. Studies on WF- 5239, a new potent platelet aggregation inhibitor. J. Antibiot. 37: 469-474 https://doi.org/10.7164/antibiotics.37.469